Showing results (531-540 of 796) with videos related to
Sort By:
Pageof 80
Anesthesiology|February 26, 1998
Hypothermic modulation of cerebral ischemic injury during cardiopulmonary bypass in pigsB P Conroy, C Y Lin, L W Jenkins, et al.Anesthesiology|March 17, 1999
Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypassB P Conroy, D Black, C Y Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesionsC C Pao, C J Tseng, C Y Lin, et al.Journal of Gastroenterology and Hepatology|March 1, 1989
A prospective evaluation of biopsy site in the diagnosis of gastric malignancy: the margin or the base?H J Lin, F Y Lee, Y T Tsai, et al.The British Journal of Dermatology|February 9, 2016
Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasisA B Kimball, A N Naegeli, E Edson-Heredia, et al.Cancer Research|November 20, 2002
Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidineCarvell T Nguyen, Daniel J Weisenberger, Mihaela Velicescu, et al.The Journal of Laboratory and Clinical Medicine|June 29, 1999
Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathyC Y Lin, F M Ku, Y C Kuo, et al.Histopathology|May 1, 1984
Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 casesH C Hsu, W Y Chen, G J Lin, et al.Sheng Li Xue Bao : [Acta Physiologica Sinica]|February 1, 1994
[Improvement of memory function of fornix-fimbria transected rats by transplantation of the superior cervical ganglion into hippocampus]A J Wang, M X Hu, H Xie, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2017
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trialsC Paul, L Guenther, H Torii, et al.Pageof 80